Evaluating New Antiviral Options

An advisory panel to the U.S. Food and Drug Administration advisory panel has voted to recommend that the FDA approve a new antiviral drug to treat COVID-19. The FDA decision is expected soon. Host Emily Kwong chats with health reporter Pien Huang on the state of treatments and how this drug and other treatment options may change the pandemic.

For more of Pien's reporting, check out "New antiviral drugs are coming for COVID. Here's what you need to know." <>

You can follow Emily on Twitter @EmilyKwong1234 and Pien @Pien_Huang. Email Short Wave at ShortWave@NPR.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy